Enwere, M.; Irobi, E.; Chime, V.; Ezeogu, A.; Onu, A.; El Hussein, M.T.; Ogungbade, G.; Davies, E.; Omoniwa, O.; Omale, C.;
et al. Metabolic Reprogramming as a Therapeutic Target in Cancer: A Qualitative Systematic Review (QualSR) of Natural Compounds Modulating Glucose and Glutamine Pathways. Onco 2025, 5, 43.
https://doi.org/10.3390/onco5030043
AMA Style
Enwere M, Irobi E, Chime V, Ezeogu A, Onu A, El Hussein MT, Ogungbade G, Davies E, Omoniwa O, Omale C,
et al. Metabolic Reprogramming as a Therapeutic Target in Cancer: A Qualitative Systematic Review (QualSR) of Natural Compounds Modulating Glucose and Glutamine Pathways. Onco. 2025; 5(3):43.
https://doi.org/10.3390/onco5030043
Chicago/Turabian Style
Enwere, Michael, Edward Irobi, Victoria Chime, Ada Ezeogu, Adamu Onu, Mohamed Toufic El Hussein, Gbadebo Ogungbade, Emmanuel Davies, Omowunmi Omoniwa, Charles Omale,
and et al. 2025. "Metabolic Reprogramming as a Therapeutic Target in Cancer: A Qualitative Systematic Review (QualSR) of Natural Compounds Modulating Glucose and Glutamine Pathways" Onco 5, no. 3: 43.
https://doi.org/10.3390/onco5030043
APA Style
Enwere, M., Irobi, E., Chime, V., Ezeogu, A., Onu, A., El Hussein, M. T., Ogungbade, G., Davies, E., Omoniwa, O., Omale, C., Neufeld, M., Akagwu, O., Atim, T., & Holmes, L., Jr.
(2025). Metabolic Reprogramming as a Therapeutic Target in Cancer: A Qualitative Systematic Review (QualSR) of Natural Compounds Modulating Glucose and Glutamine Pathways. Onco, 5(3), 43.
https://doi.org/10.3390/onco5030043
